摘要 |
The present invention therefore provides a method of treatment patients at risk of so-called sudden death caused by fatal atherothrombosclerotic conditions and which treatment is intended to promote survival, characterized by a chronic administration to the patient of a compound of the general formula <IMAGE> I or a pharmaceutically acceptable acid addition salt thereof, in which R represents a straight or branched alkyl group of 1-4 (incl.) carbon atoms, Ar, Ar' represent both an aromatic group, and A is a tertiary amino group selected from di-alkylamino and a nitrogen containing 5- or 6-membered ring, in an effective dialy dosage.
|